130 related articles for article (PubMed ID: 17349336)
1. Low molecular weight heparin suppresses tumor necrosis factor expression from deep vein thrombosis.
Carr JA; Cho JS
Ann Vasc Surg; 2007 Jan; 21(1):50-5. PubMed ID: 17349336
[TBL] [Abstract][Full Text] [Related]
2. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.
Downing LJ; Strieter RM; Kadell AM; Wilke CA; Greenfield LJ; Wakefield TW
J Vasc Surg; 1998 Nov; 28(5):848-54. PubMed ID: 9808852
[TBL] [Abstract][Full Text] [Related]
3. Effect of low molecular weight heparin on pancreatic micro-circulation in severe acute pancreatitis in a rodent model.
Qiu F; Lü XS; Huang YK
Chin Med J (Engl); 2007 Dec; 120(24):2260-3. PubMed ID: 18167214
[TBL] [Abstract][Full Text] [Related]
4. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
Deepa PR; Varalakshmi P
Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
[TBL] [Abstract][Full Text] [Related]
5. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.
Thanaporn P; Myers DD; Wrobleski SK; Hawley AE; Farris DM; Wakefield TW; Henke PK
Surgery; 2003 Aug; 134(2):365-71. PubMed ID: 12947342
[TBL] [Abstract][Full Text] [Related]
6. [Effects of low molecular weight heparin on the inflammatory response and vascular injury in rat after electric burn].
Jiang N; Xie W; Wang H; Jin D; Tan H; Zhao C
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):128-33. PubMed ID: 24989657
[TBL] [Abstract][Full Text] [Related]
7. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
Blatný J; Fiamoli V
Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
[TBL] [Abstract][Full Text] [Related]
8. Prevention effect of orally active heparin derivative on deep vein thrombosis.
Kim SK; Lee DY; Kim CY; Moon HT; Byun Y
Thromb Haemost; 2006 Aug; 96(2):149-53. PubMed ID: 16894457
[TBL] [Abstract][Full Text] [Related]
9. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats.
Zhou J; May L; Liao P; Gross PL; Weitz JI
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):863-9. PubMed ID: 19265029
[TBL] [Abstract][Full Text] [Related]
10. P-selectin and TNF inhibition reduce venous thrombosis inflammation.
Wakefield TW; Strieter RM; Downing LJ; Kadell AM; Wilke CA; Burdick MD; Wrobleski SK; Phillips ML; Paulson JC; Anderson DC; Greenfield LJ
J Surg Res; 1996 Jul; 64(1):26-31. PubMed ID: 8806469
[TBL] [Abstract][Full Text] [Related]
11. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
14. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
[TBL] [Abstract][Full Text] [Related]
15. A newly developed oral heparin derivative for deep vein thrombosis: non-human primate study.
Kim SK; Lee DY; Kim CY; Nam JH; Moon HT; Byun Y
J Control Release; 2007 Nov; 123(2):155-63. PubMed ID: 17884230
[TBL] [Abstract][Full Text] [Related]
16. Role of heparin on TNF-alpha and IL-6 levels in liver regeneration after partial hepatic resection.
Yuceturk H; Yagmurdur MC; Gur G; Demirbilek M; Bilezikci B; Turan M; Karakayali H; Haberal M
Eur Surg Res; 2007; 39(4):216-21. PubMed ID: 17438357
[TBL] [Abstract][Full Text] [Related]
17. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Deepa PR; Varalakshmi P
Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
[TBL] [Abstract][Full Text] [Related]
18. Anti-thrombosis effect of LRRFIP1 shRNA lentivirus in a mouse model of deep vein thrombosis.
Yin X; Wu S; Wang Z; Wang Y; Du Q; Wang A
Thromb Res; 2013 Jul; 132(1):127-31. PubMed ID: 23751182
[TBL] [Abstract][Full Text] [Related]
19. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW
Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610
[TBL] [Abstract][Full Text] [Related]
20. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
Naz R; Naz S; Mehboob M; Khalid GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
